Oramed Pharmaceuticals (ORMP) Other Non-Current Assets (2016 - 2026)
Oramed Pharmaceuticals (ORMP) posted Other Non-Current Assets of $46000.0 for Q1 2026, up 4.55% on a QoQ basis from $44000.0 in Q4 2025, and up 2200.0% year-over-year from $2000.0 in Q1 2025.
Oramed Pharmaceuticals (ORMP) Other Non-Current Assets (2016 - 2026) Analysis & Trends
Oramed Pharmaceuticals' Other Non-Current Assets history runs 10 years deep, the most recent figure standing at $46000.0 for Q1 2026.
- Quarterly Other Non-Current Assets rose 2200.0% year-over-year to $46000.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $46000.0 (up 2200.0% YoY) and the FY2025 annual result came in at $44000.0, up 2100.0% from the prior year.
- Other Non-Current Assets was $46000.0 for Q1 2026 at Oramed Pharmaceuticals, up from $44000.0 in the prior quarter.
- Across five years, Other Non-Current Assets topped out at $111.5 million in Q4 2022 and bottomed at $2000.0 in Q2 2024.
- A 5-year average of $8.6 million and a median of $7000.0 in 2023 frame the typical range for Other Non-Current Assets.
- Annual changes were most pronounced in 2023 — Other Non-Current Assets sank 99.98% — and 2026, when it jumped 2200.0%.
- Oramed Pharmaceuticals' Other Non-Current Assets stood at $111.5 million in 2022, then sank by 99.98% to $27000.0 in 2023, then tumbled by 92.59% to $2000.0 in 2024, then surged by 2100.0% to $44000.0 in 2025, then gained by 4.55% to $46000.0 in 2026.
- Business Quant data shows ORMP's Other Non-Current Assets at $46000.0 in Q1 2026, $44000.0 in Q4 2025, and $40000.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Other Non-Current Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | 1.02 Mn |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 104.24 Mn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 1.26 Bn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | 2.13 Bn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | 289.41 Mn |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | 124.00 Mn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | 14.48 Mn |
| 10 | Oramed Pharmaceuticals | 170.25 Mn | 170.25 Mn | - | 46,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 46,000.00 |
| Dec 31, 2025 | 44,000.00 |
| Sep 30, 2025 | 40,000.00 |
| Jun 30, 2025 | 38,000.00 |
| Mar 31, 2025 | 2,000.00 |
| Dec 31, 2024 | 2,000.00 |
| Sep 30, 2024 | 2,000.00 |
| Jun 30, 2024 | 2,000.00 |
| Mar 31, 2024 | 7,000.00 |
| Dec 31, 2023 | 27,000.00 |
| Sep 30, 2023 | 6,000.00 |
| Jun 30, 2023 | 7,000.00 |
| Dec 31, 2022 | 111.51 Mn |
| Aug 31, 2021 | 11.04 Mn |
| Aug 31, 2020 | 11.06 Mn |
| Aug 31, 2018 | 13.54 Mn |
| Nov 30, 2017 | 17.78 Mn |
| Aug 31, 2017 | 16.23 Mn |
| Aug 31, 2016 | 11.04 Mn |